Sort by
Refine Your Search
-
Researcher (R2) Application Deadline 2 Oct 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 4 Jan 2027 Is the job funded through the EU
-
(R1) Application Deadline 25 Sep 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Oct 2026 Is the job funded through the EU
-
) Application Deadline 2 Oct 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Dec 2026 Is the job funded through the EU Research Framework
-
postdoctoral researcher to join our group at the Institute of Genetics and Development in Rennes (IGDR), France (https://igdr.univ-rennes.fr/en ). Research in the Cyclochondria team led by Giulia Bertolin (https
-
lines, as well as high-resolution live-cell imaging techniques. Where to apply Website https://emploi.cnrs.fr/Offres/Doctorant/UMR5237-JERBOU-001/Default.aspx Requirements Research FieldBiological
-
12 Sep 2026 Job Information Organisation/Company CNRS Department Institut de Génétique Humaine Research Field Biological sciences Researcher Profile Established Researcher (R3) Application Deadline
-
on the progress of their experiments. Additional comments Application deadline: October 2, 2026. Website for additional job details https://emploi.cnrs.fr/Offres/CDD/UMR7242-OLICUN-002/Default.aspx
-
Researcher Profile Recognised Researcher (R2) Application Deadline 2 Oct 2026 - 23:59 (UTC) Country France Type of Contract Temporary Job Status Full-time Hours Per Week 35 Offer Starting Date 1 Nov 2026 Is
-
an electrolysis cell. In particular, stability will be assessed using accelerated degradation tests, and the structural and morphological evolution of the catalysts will be monitored via physicochemical techniques
-
, integrating statistical inference, machine learning, and population genetics. We will develop advanced computational methods to characterize the functioning of T- and B-cell repertoires. The goal is to build